C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2002
11/27/2002	CN1381467A Polypeptide-human zinc finger protein-32.56 and polynucleotide for coding it
11/27/2002	CN1381466A Polypeptide-human zinc finger protein-26.84 and polynucleotide for coding it
11/27/2002	CN1381461A Light chain or heavy chain variable region gene of human liver cancer monoclonal antibody HAb18 and its application
11/26/2002	US6486311 Peanut allergens and methods
11/26/2002	US6486305 Method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
11/26/2002	US6486299 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/26/2002	US6486131 As diagnostic and therapeutic assays and reagents for detecting and therapy of proliferative disorders arising from, for example, tumorigenic transformation of cells, or other hyperplastic or neoplastic transformation processes
11/26/2002	US6485970 Immunointeractive antibody
11/26/2002	US6485968 Ectoparasite saliva proteins and apparatus to collect such proteins
11/26/2002	US6485960 Polycystic kidney disease 1 gene and uses thereof
11/26/2002	US6485957 DNA encoding the human serine protease EOS
11/26/2002	US6485943 Method for altering antibody light chain interactions
11/26/2002	US6485932 Composition comprising immunoglobulin
11/26/2002	US6485929 Method for inhibiting CD95-independent apoptosis in AIDS
11/26/2002	US6485919 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
11/26/2002	US6485914 Method of detecting chlamydia pneumoniae gene using polynucleotides
11/26/2002	US6485911 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 2 (PS-2) gene
11/26/2002	US6485725 Room temperature storable immunoglobulin preparation for intravenous injection
11/26/2002	CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002	CA2111573C Cadherin materials and methods
11/26/2002	CA2107672C Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
11/26/2002	CA2098838C Liver enriched transcription factor
11/26/2002	CA2087164C Target specific antibody-superantigen conjugates and their preparation
11/26/2002	CA2086643C Oxepane isomers of rapamycin useful as immunosuppressive agents
11/23/2002	CA2382443A1 Use of anti-ctla-4 antibodies
11/22/2002	CA2383004A1 Non-anaphylactogenic ige vaccines
11/21/2002	WO2002093519A2 Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
11/21/2002	WO2002093128A2 Identifying insulin response modulators and therapeutic uses thereof
11/21/2002	WO2002092842A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002	WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	WO2002092837A2 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
11/21/2002	WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/21/2002	WO2002092819A1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same
11/21/2002	WO2002092812A1 ARTIFICIAL HUMAN CHROMOSOME CONTAINING HUMAN ANTIBODY μ LIGHT CHAIN GENE
11/21/2002	WO2002092809A1 Novel hexenuronidase, gene coding for the same, and use of these
11/21/2002	WO2002092801A2 Methods and compositions for making emamectin
11/21/2002	WO2002092788A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092771A2 Specific binding proteins and uses thereof
11/21/2002	WO2002092770A2 Novel method for cloning variable domain sequences of immunological gene repertoire
11/21/2002	WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002	WO2002092762A2 Cytokine polypeptides
11/21/2002	WO2002092759A2 Molecules for disease detection and treatment
11/21/2002	WO2002092758A2 Gastrokines and derived peptides including inhibitors
11/21/2002	WO2002092635A2 Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
11/21/2002	WO2002092634A2 Specific antibodies for histamine receptor subclasses
11/21/2002	WO2002092632A1 Method for preparing human immunoglobulin concentrates for therapeutic use
11/21/2002	WO2002092620A2 Peptides and related molecules that bind to tall-1
11/21/2002	WO2002092133A1 Angiogenesis inhibitors
11/21/2002	WO2002092131A2 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
11/21/2002	WO2002092127A1 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26
11/21/2002	WO2002092126A1 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer
11/21/2002	WO2002092125A1 Compositions for use in treating ige-associated disorders
11/21/2002	WO2002092020A2 Compositions and methods for modulating bone mineral deposition
11/21/2002	WO2002092017A2 Human antipneumococcal antibodies from non-human animals
11/21/2002	WO2002092016A2 Therapeutic use of rank antagonists
11/21/2002	WO2002092015A2 Reagents and methods for modulating dkk-mediated interactions
11/21/2002	WO2002092012A2 Compositions and methods for treating tumors bearing hmfg and cea antigens
11/21/2002	WO2002092011A2 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
11/21/2002	WO2002092008A2 Use of il-18 inhibitors for the treatement or prevention of sepsis
11/21/2002	WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002	WO2002092000A2 Hbm variants that modulate bone mass and lipid levels
11/21/2002	WO2002079447A9 Avian lysozyme promoter
11/21/2002	WO2002077211A8 A virus (cryptovirus) within the rubulavirus genus and uses therefor
11/21/2002	WO2002076377A3 Mononucleosome and process for producing the same, method of assaying antibody specific to nucleosome, method of diagnosing autoimmune disease, process for producing nucleosome dna, dna plate, process for producing dna plate and method of assaying anti-dna antibody
11/21/2002	WO2002074981A3 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
11/21/2002	WO2002059604A8 Diagnosis and treatment of multiple sclerosis
11/21/2002	WO2002057290A3 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
11/21/2002	WO2002055089B1 Immunoassay technique using multispecific molecules
11/21/2002	WO2002044217A3 Humanised antibodies and uses thereof
11/21/2002	WO2002014467A3 Cng2b: a putative human cyclic nucleotide-gated ion channel
11/21/2002	WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002	US20020174453 Production of antibodies in transgenic plastids
11/21/2002	US20020173638 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
11/21/2002	US20020173629 Antibody for use in the treatment of cancer
11/21/2002	US20020173628 Chimeric IL-10 proteins and uses thereof
11/21/2002	US20020173624 Polypeptide for use in treatment and prevention of liver, nervous system and glandular disorders
11/21/2002	US20020173621 Generation of preferential fusion protein; obtain cell, transform with expression vector coding fusion polypeptide, propagate, express vector, recover fusion protein
11/21/2002	US20020173477 Antiallergens
11/21/2002	US20020173475 Methods to inhibit viral replication
11/21/2002	US20020173463 Isolated nucleic acids; and antibodies
11/21/2002	US20020173461 Methods for enhancing the efficacy of cancer therapy
11/21/2002	US20020173458 Polypeptides; genetic engineering
11/21/2002	US20020173457 Polypeptides
11/21/2002	US20020173035 Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same
11/21/2002	US20020173022 Polypeptide for use in the diagnosis, prevention and treatment of inflammation and disorders associated with cell proliferation and apoptosis
11/21/2002	US20020173007 Human chemokine polypeptides
11/21/2002	US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002	US20020172978 Methods and kits for diagnosing or monitoring synovial or osteoarticular disease, comprising the use of a specific marker for synovial tissue degradation
11/21/2002	US20020172959 Compositions and methods relating to lung specific genes and proteins
11/21/2002	US20020172941 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
11/21/2002	US20020172680 Diagnosis of metastatic cancer by the mts-1 gene
11/21/2002	US20020172678 For regulating cellular proliferation and chemotaxis
11/21/2002	US20020172677 Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies
11/21/2002	US20020172675 Methods for detecting and inhibiting angiogenesis
11/21/2002	US20020172674 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth
11/21/2002	US20020172673 Method for down-regulating IgE
11/21/2002	US20020172671 CAIP-like gene family
11/21/2002	US20020172660 For therapy of cancer, viral infections
11/21/2002	CA2826627A1 Specific binding proteins and uses thereof

1 ... 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 ... 1494